SEARCH

SEARCH BY CITATION

References

  • Ackerman, G.A. (1968) Ultrastructure and cytochemistry of the developing neutrophil. Laboratory Investigation, 19, 290294.
  • Béné, M.C., Castoldi, G., Knapp, W., Ludwig, W.D., Matutes, E., Orfao, A., Van′t Veer, M.B. on behalf of EGIL (1995) Proposals for the immunological classification of acute leukemias. Leukemia, 9, 17831786.
  • Béné, M.C., Bernier, M., Casasnovas, R.O., Castoldi, G., Knapp, W., Lanza, F., Ludwig, W.-D., Matutes, E., Orfao, A., Sperling, C., Van′t Veer, M.B. on behalf of EGIL (1998) The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. Blood, 92, 596599.
  • Béné, M.C., Bernier, M., Castoldi, G., Faure, G.C., Knapp, W., Ludwig, W.-D., Matutes, E., Orfao, A., Van′t Veer, M.B. on behalf of EGIL (1999) Impact of immunophenotyping on management of acute leukemias. Haematologica, 84, 10241034.
  • Bennett, J.M. & Reed, C.E. (1975) Acute leukaemia cytochemical profile: diagnostic and clinical implications. Blood Cells, 1, 101108.
  • Bennett, J.M., Catovsky, D., Daniel, M.T.G., Flandrin, G., Galton, D.A.G., Gralnick, H.R.R., Sultan, C. (1991) Proposals for the recognition of minimally differentiated acute myeloid leukaemia. British Journal of Haematology, 78, 325329.
  • Bessis, M. & Maigné, J. (1970) Diagnosis of acute leukemia varieties by peroxidase reaction studied by electron microscopy. Its value and its limitations. Review of European Etudes in Clinical Biology, 15, 691698.
  • Bitter, M.A., Le Beau, M.M., Rowley, J.D., Larson, R.A., Golomb, H.M., Vardiman, J.W. (1987) Association between morphology, karyotype and clinical features in myeloid leukemias. Human Pathology, 18, 211225.
  • Campana, D., Hansen-Hagge, T.E., Matutes, E., Coustan-Smith, E., Yokota, S., Shetty, V., Bartram, C.R., Janossy, G.G. (1990) Phenotypic, genotypic, cytochemical and ultrastructural characterization of acute undifferentiated leukemia. Leukemia, 4, 620624.
  • Campos, L., Guyotot, D., Archimbaud, E., Devaux, Y., Treille, D., Larese, A., Maupas, J., Gentilhomme, O., Ehrsam, A., Fiere, D. (1989) Surface marker expression in adult myeloid leukaemia: correlations with initial characteristics, morphology and respons to therapy. British Journal of Haematology, 72, 161166.
  • Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J., Treille, D., Fiere, D. (1992) Clinical significance of multidrug resistence p-glycoprotein expression on acute non lymphoblastic leukemia cell at diagnosis. Blood, 79, 473476.
  • Cohen, P., Hoyer, J.D., Kurtin, P.J., D. (1998) Acute myeloid leukemia with minimal differentiation. a multiple parameter study. American Journal of Clinical Pathology, 109, 35.
  • Costello, R.T., Mallet, F., Chambost, H., Sainty, D., Arnoulet, C., Gastaut, J.-A., Olive, D. (1999) The immunophenotype of minimally differentiated acute myeloid leukemia (AML M0). reduced immunogenicity and high frequency of CD34+/CD38 leukemic progenitors. Leukemia, 13, 15131518.
  • Creutzig, U., Harbott, J., Sperling, C., Ritter, J., Zimmerman, M., Loffler, H., Riehm, H.S., Schelling, G., Ludwig, W.-D. (1995) Clinical significance of surface antigen expression in children with acute myeloid leukemia. results of study AML-BFM-87. Blood, 86, 30973108.
  • Cuneo, A., Ferrari, A., Michaux, J.L., Boogaerts, M., Demuync, H., Van Orshoven, A., Criel, A., Stul, M., Dal Cin, P., Hernandez, J., Chatelain, B., Doyen, C., Louwagie, A., Castoldi, G., Cassiman, J.J., Van Den Berghe, H. (1995) Cytogenetic profile of minimally differentiated (FAB MO) acute myeloid leukemia. Correlation with chemico-biological findings. Blood, 85, 36883694.
  • Galton, D.A.G., Dacie, J.V., Peto, R. (1975) The relation between morphology and other features of acute myeloid leukaemia and their prognostic significance. British Journal of Haematology, 31, 165.
  • Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller Hermelink, H.K., Vardiman, J., Lister, T.A., Bloomfield, C.D. (1999) World Health Organisation classification of neoplastic diseases of the haemotopoietic and lymphoid tissue: report of the clinical advisory committee meeting – Airlie House Virginia, November 1997. Journal of Clinical Oncology, 17, 38353849.
  • Huang, S.-Y., Tang, J.-L., Jou, S.-T., Tsay, W., Hu, C.-H., Lin, D.-T., Wang, C.-H., Chen, Y.-C., Shen, M.-C. (1999) Minimally differentiated acute myeloid leukemia in Taiwan predominantly occurs in children less than 3 years and adults between 51 and 70 years. Leukemia, 13, 15061512.
  • Imamura, M. & Kuramoto, A. (1988) Acute unclassifiable leukaemia in adults, demonstrating myeloid antigen and myeloperoxydase proteins. British Journal of Haematology, 69, 427428.
  • Lee, E.J., Pollak, A., Testa, J., R., Schiffer, C.A. (1987) Minimally differentiated acute non lymphocytic leukemia. a distinct entity. Blood, 70, 14001406.
  • Le Maistre. A., Childs, C.A., Hirsch Ginsberg, C., Reuben, J., Cork, A., Trujillo, J.M., Andersson, B., McCredie, K.B., Freireich, E., Stass, S.A. (1988) Heterogeneity in acute undifferentiated leukemia. Hematological Pathology, 2, 7990.
  • Lemež, P. (1985) Cytochemical examinations of cultivated unclassified leukaemic cells. Histochemistry Journal, 17, 13771380.
  • Lemež, P., Michalová, K., Zemanová, Z., Marinov, I., Trpakova, A., Moravcova, J., Jelinek, J. (1998) Three cases of near-tetraploid acute myeloid leukemias originating in pluripotent myeloid progenitors. Leukemia Research, 22, 581588.
  • Marie, J.P., Perrot, J.Y., Boucheix, C., Zittoun, J., Martyre, M.C., Kayibanda, M., Rosenfeld, C., Mishal, Z., Zittoun, R. (1982) Determination of ultrastructural peroxidases and immunological membrane markers in the diagnosis of acute leukemias. Blood, 59, 270276.
  • Matutes, E., Pombo de Oliveira, M., Foroni, L., Morilla, R., Catovsky, D. (1988) The role of ultrastructural cytochemistry and monoclonal antibodies in clarifying the nature of undifferentiated cells in acute leukaemia. British Journal of Haematology, 69, 205211.
  • Mitelman, F. (ed.) (1995) ISCN: An international system for human cytogenetic nomenclature. Published in collaboration with Cytogenetics and Cellgenetics. S Karger, Basel, Switzerland.
  • Mori, H., Tawara, M., Yoshida, Y., Kuriyama, K., Sugahara, K., Kamihira, S., Tomonaga, S. (2000) Minimally differentiated acute myeloid leukemia (AML M0) with extensive erythrophagocytosis and del (20) (q11) chromosome abnormality. Leukemia Research, 24, 8790.
  • Paietta, E., Racevskis, J., Bennett, J.M., Neuberg, D., Cassileth, P.A., Rowe, J.W., Wiernik, P.H. (1998) Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience. Leukemia, 12, 18811885.
  • Segeren, C.M., De Jong-Gerrits, G.C.M.M., & van ′t Veer, M.B. (1995) AML-M0 clinical entity or waste basket for immature blastic leukemias? A description of 14 patients. Annals of Hematology, 70, 297300.
  • Sempere, A., Jarque, I., Guinot, M., Palau, J., Garcia, R., Sanz, G.F., Gomis, F., Perez-Sirvent, M.L., Sanz, S.L. (1993) Acute myeloblastic leukemia with minimal myeloid differentiation (FAB M0): a study of eleven cases. Leukemia and Lymphoma, 12, 103108.
  • Stasi, R., Del Poeta, G., Venditti, A., Masi, M., Stipa, E., Dentamaro, T., Cox, C., Dallapicolo, B., Papa, G. (1994) Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML M0). Blood, 83, 16191625.
  • Van Der Schoot, C.E., Daams, G.M., Pinkster, J., Vet, R., Von Dem Borne, A.E.G.KR. (1990) Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukaemia. British Journal of Haematology, 74, 173178.
  • Van Wering, E.R., Brederoo, P., Van Dijk - de Leeuw, J.H.S., Van Der Meulen, J., Van'T Veer, M.B. (1990) Electron microscopy. a contribution to further classification of acute unclassifiable childhood leukaemia. Blut, 60, 291296.
  • Venditti, A., Delpoeta, G., Stasi, R., Masi, M., Bruno, A., Buccisani, F., Cox, C., Coppetelli, U., Aronica, G., Simone, M.D., Papa, G., Tribalto, M., Amadori, S. (1994) Minimally differentiated acute myeloid leukaemia (AML-M0) Cytochemical, immunophenotypic and cytogenetic analysis in 19 cases. British Journal of Haematology, 88, 784793.
  • Venditti, A., Del Poeta, G., Buccisano, F., Tamburini, A., Cox, M.C., Stasi, R., Bruno, A., Aricona, G., Maffei, L., Suppo, G., Simone, M.D., Forte, L., Cordero, V., Posterino, M., Tufilli, V., Isacchi, G., Masi, M., Papa, G., Amadori, M. (1997) Minimally differentiated acute myeloid leukemia (AML M0): comparison of 25 cases with other French-American-British subtypes. Blood, 89, 621629.
  • Villamor, N., Zarco, M.A., Rozman, M., Ribera, J.-M., Felice, E., Montserrat, E. (1998) Acute myeloblastic leukemia with minimal myeloid differentiation: phenotypical and ultrastructural characteristics. Leukemia, 12, 10711075.
  • Visser, J.W.M. & Van Bekkum, D.W. (1990) Purification of pluripotent hematopoietic stem cells: past and present. Experimental Haematology, 18, 248256.
  • Wuchter, C., Karawajew, L., Ruppert, V., Schrappe, M., Harbott, J., Ratei, R., Dorken, B., Ludwig, W.-D. (1999) Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in the context of P glycoprotein function, maturation stage, and cytogenetics. Leukemia, 13, 19431953.